Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis
Epitopes on the surface of the foot-and-mouth disease virus (FMDV) capsid have been identified by monoclonal antibody (mAb) escape mutant studies leading to the designation of four antigenic sites in serotype A FMDV. Previous work focused on viruses isolated mainly from Asia, Europe and Latin America. In this study we report on the prediction of epitopes in African serotype A FMDVs and testing of selected epitopes using reverse genetics. Twenty-four capsid amino acid residues were predicted to be of antigenic significance by analysing the capsid sequences (n = 56) using in silico methods, and six residues by correlating capsid sequence with serum–virus neutralization data. The predicted residues were distributed on the surface-exposed capsid regions, VP1–VP3. The significance of residue changes at eight of the predicted epitopes was tested by site-directed mutagenesis using a cDNA clone resulting in the generation of 12 mutant viruses involving seven sites. The effect of the amino acid substitutions on the antigenic nature of the virus was assessed by virus neutralization (VN) test. Mutations at four different positions, namely VP1-43, VP1-45, VP2-191 and VP3-132, led to significant reduction in VN titre (P value = 0.05, 0.05, 0.001 and 0.05, respectively). This is the first time, to our knowledge, that the antigenic regions encompassing amino acids VP1-43 to -45 (equivalent to antigenic site 3 in serotype O), VP2-191 and VP3-132 have been predicted as epitopes and evaluated serologically for serotype A FMDVs. This identifies novel capsid epitopes of recently circulating serotype A FMDVs in East Africa.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
AshkenazyH., ErezE., MartzE., PupkoT., Ben-TalN.2010; ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res 38:Web Server issueW529–W533 [View Article][PubMed]
BahnemannH. G.1975; Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. Arch Virol 47:47–56 [View Article][PubMed]
BahnemannH. G.1990; Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine. Vaccine 8:299–303 [View Article][PubMed]
BariF. D., ParidaS., TekleghiorghisT., DekkerA., SangulaA., ReeveR., HaydonD. T., PatonD. J., MahapatraM.2014; Genetic and antigenic characterisation of serotype A FMD viruses from East Africa to select new vaccine strains. Vaccine 32:5794–5800 [View Article][PubMed]
BaxtB., VakhariaV., MooreD. M., FrankeA. J., MorganD. O.1989; Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. J Virol 63:2143–2151[PubMed]
BorleyD. W., MahapatraM., PatonD. J., EsnoufR. M., StuartD. I., FryE. E.2013; Evaluation and use of in-silico structure-based epitope prediction with foot-and-mouth disease virus. PLoS ONE 8:e61122 [View Article][PubMed]
BøtnerA., KakkerN. K., BarbezangeC., BerrymanS., JacksonT., BelshamG. J.2011; Capsid proteins from field strains of foot-and-mouth disease virus confer a pathogenic phenotype in cattle on an attenuated, cell-culture-adapted virus. J Gen Virol 92:1141–1151 [View Article][PubMed]
ChitrayM., de BeerT. A. P., VoslooW., MareeF. F.2014; Genetic heterogeneity in the leader and P1-coding regions of foot-and-mouth disease virus serotypes A and O in Africa. Arch Virol 159:947–961[PubMed]
CrowtherJ. R., FariasS., CarpenterW. C., SamuelA. R.1993; Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol 74:1547–1553 [View Article][PubMed]
FerrisN. P., DonaldsonA. I., BarnettI. T. R., OsborneR.W.1984; Inactivation, purification and stability of 146S antigens of foot-and-mouth disease virus for use as reagents in the complement fixation test. Rev Sci Tech 3:339–350
FryE. E., NewmanJ. W. I., CurryS., NajjamS., JacksonT., BlakemoreW., LeaS. M., MillerL., BurmanA. et al.2005; Structure of foot-and-mouth disease virus serotype A1061 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J Gen Virol 86:1909–1920 [View Article][PubMed]
GrazioliS., FallacaraF., BrocchiE.2013; Mapping of antigenic sites of foot-and-mouth disease virus serotype Asia 1 and relationships with sites described in other serotypes. J Gen Virol 94:559–569 [View Article][PubMed]
JamalS. M., FerrariG., AhmedS., NormannP., CurryS., BelshamG. J.2011; Evolutionary analysis of serotype A foot-and-mouth disease viruses circulating in Pakistan and Afghanistan during 2002–2009. J Gen Virol 92:2849–2864 [View Article][PubMed]
KitsonJ. D. A., McCahonD., BelshamG. J.1990; Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179:26–34 [View Article][PubMed]
KumarR. M., SanyalA., HemadriD., ToshC., MohapatraJ. K., BandyopadhyayS. K.2004; Characterization of foot-and-mouth disease serotype asial viruses grown in the presence of polyclonal antisera in serology and nucleotide sequence analysis. Arch Virol 149:1801–1814[PubMed]
LandauM., MayroseI., RosenbergY., GlaserF., MartzE., PupkoT., Ben-TalN.2005; ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res 33:Web Server issueW299–W302 [View Article][PubMed]
LawrenceP., PachecoJ. M., UddowlaS., HollisterJ., KotechaA., FryE., RiederE.2013; Foot-and-mouth disease virus (FMDV) with a stable FLAG epitope in the VP1 G-H loop as a new tool for studying FMDV pathogenesis. Virology 436:150–161 [View Article][PubMed]
MahapatraM., SekiC., UpadhyayaS., BarnettP. V., La TorreJ., PatonD. J.2011; Characterisation and epitope mapping of neutralising monoclonal antibodies to A24 Cruzeiro strain of FMDV. Vet Microbiol 149:242–247 [View Article][PubMed]
MareeF. F., BlignautB., EsterhuysenJ. J., de BeerT. A. P., TheronJ., O’NeillH. G., RiederE.2011; Predicting antigenic sites on the foot-and-mouth disease virus capsid of the South African Territories types using virus neutralization data. J Gen Virol 92:2297–2309 [View Article][PubMed]
MateuM. G., CamareroJ. A., GiraltE., AndreuD., DomingoE.1995; Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206:298–306 [View Article][PubMed]
McCahonD., CrowtherJ. R., BelshamG. J., KitsonJ. D., DuchesneM., HaveP., MeloenR. H., MorganD. O., De SimoneF.1989; Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants. J Gen Virol 70:639–645 [View Article][PubMed]
OppermanP. A., RotherhamL. S., EsterhuysenJ., CharlestonB., JuleffN., CapozzoA. V., TheronJ., MareeF. F.2014; Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses. J Virol 88:8307–8318 [View Article][PubMed]
PanK., DeemM. W.2011; Quantifying selection and diversity in viruses by entropy methods, with application to the haemagglutinin of H3N2 influenza. J R Soc Interface 8:1644–1653 [View Article][PubMed]
PayT. W., HingleyP. J.1987; Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines. Vaccine 5:60–64 [View Article][PubMed]
PiattiP., HassardS., NewmanJ. F. E., BrownF.1995; Antigenic variants in a plaque-isolate of foot-and-mouth disease virus: implications for vaccine production. Vaccine 13:781–784 [View Article][PubMed]
QiT., QiuT., ZhangQ., TangK., FanY., QiuJ., WuD., ZhangW., ChenY. et al.2014; SEPPA 2.0–more refined server to predict spatial epitope considering species of immune host and subcellular localization of protein antigen. Nucleic Acids Res 42:Web Server issueW59–W63 [View Article][PubMed]
ReeveR., BlignautB., EsterhuysenJ. J., OppermanP., MatthewsL., FryE. E., de BeerT. A. P., TheronJ., RiederE. et al.2010; Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus. PLOS Comput Biol 6:e1001027 [View Article][PubMed]
RojasE. R., CarrilloE., SchiappacassiM., CamposR.1992; Modification of foot-and-mouth disease virus O1 Caseros after serial passages in the presence of antiviral polyclonal sera. J Virol 66:3368–3372[PubMed]
RweyemamuM. M., HingleyP. J.1984; Food and mouth disease virus strain differentiation: analysis of the serological data. J Biol Stand 12:225–229 [View Article][PubMed]
SaizJ. C., GonzalezM. J., BorcaM. V., SobrinoF., MooreD. M.1991; Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol 65:2518–2524[PubMed]
SarangiL. N., MohapatraJ. K., SubramaniamS., SanyalA., PattnaikB.2013; Antigenic site variation in foot-and-mouth disease virus serotype O grown under vaccinal serum antibodies in vitro
. Virus Res 176:273–279 [View Article][PubMed]
ToshC., VenkataramananR., PattnaikB., HemadriD., SanyalA.1999; Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus. Acta Virol 43:219–225[PubMed]
van RensburgH. G., HenryT. M., MasonP. W.2004; Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus. J Gen Virol 85:61–68 [View Article][PubMed]
WekesaS. N., SangulaA. K., BelshamG. J., MuwanikaV. B., HellerR., BalindaS. N., MasembeC., SiegismundH. R.2014; Genetic diversity of serotype A foot-and-mouth disease viruses in Kenya from 1964 to 2013; implications for control strategies in eastern Africa. Infect Genet Evol 21:408–417 [View Article][PubMed]
YangG., LiS., BlackmonS., YeJ., BradleyK. C., CooleyJ., SmithD., HansonL., CardonaC. et al.2013; Mutation tryptophan to leucine at position 222 of haemagglutinin could facilitate H3N2 influenza A virus infection in dogs. J Gen Virol 94:2599–2608 [View Article][PubMed]
Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis